May 20, 2025
Actimed Therapeutics Announces New Programme to Investigate Potential Muscle Preservation Effects of S-pindolol Benzoate in Obese Patients Treated with GLP-1 Agonists
Apr 24, 2025
Actimed Therapeutics Appoints Shaun Claydon as Chief Financial Officer